| 2-Propenamide, 2-cyano-3-(5-(2,5-dichlorophenyl)-2-furanyl)-N-5-quinolinyl- | IC50 | 3500.0 [1] |
| Sirtinol | IC50 | 45900.0 [1] |
| 6-Chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide | IC50 | 19600.0 [1] |
| Cambinol | IC50 | 51000.0 [1] |
| Nicotinamide | IC50 | 11000.0 [1] |
| N-[3-[(2-Oxo-1-naphthalenylidene)methylamino]phenyl]-2-phenylpropanamide | IC50 | 25000.0 [1] |
| Tenovin-6 | IC50 | 10000.0 [1] |
| 2-[(4,6-Dimethylpyrimidin-2-yl)sulfanyl]-N-[5-(naphthalen-1-ylmethyl)-1,3-thiazol-2-yl]acetamide | IC50 | 140.0 [1], 400.0 [2], 440.0 [3], 3388.44 [4] |
| 3-(Azepan-1-ylsulfonyl)-N-(3-bromophenyl)benzamide | IC50 | 15500.0 [1], 16000.0 [2] |
| SIRT2 Inhibitor II, AK-1 | IC50 | 10800.0 [1], 12500.0 [2] |
| 10-Phenyl-7-oxa-8,10-diaza-benzo[a]anthracene-9,11-dione | IC50 | 12300.0 [1], 191200.0 [2] |
| Bisindolylmaleimide IX | IC50 | 800.0 [1], 1100.0 [2] |
| 2-Thioxo-1,2-dihydro-5-[(biphenyl-4-yl)methylene]pyrimidine-4,6(3H,5H)-dione | IC50 | 8700.0 [1] |
| 3-[(2-Methoxynaphthalen-1-yl)methyl]-7-(pyridin-3-ylmethylamino)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-one | IC50 | 170.0 [1], 1450.0 [2] |
| 3-[(2-Methoxynaphthalen-1-yl)methyl]-7-(pyridin-3-ylmethylamino)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-one | Ki | 620.0 [1] |
| Bisindolylmaleimide i | IC50 | 7300.0 [1], 11700.0 [2] |
| 8-[4-Methyl-3-[(5Z)-5-[(Z)-[5-[[2-methyl-5-[(4,6,8-trisulfo-2H-naphthalen-1-ylidene)carbamoyl]cyclohexa-2,4-dien-1-ylidene]carbamoyl]cyclohexa-2,4-dien-1-ylidene]carbamoyl]iminocyclohexa-1,3-diene-1-carbonyl]iminocyclohexa-1,4-diene-1-carbonyl]imino-7H-naphthalene-1,3,5-trisulfonic acid | IC50 | 1150.0 [1], 13000.0 [2], 14000.0 [3] |
| Paullone | IC50 | 10000.0 [1], 42800.0 [2] |
| Bisindolylmaleimide v | IC50 | 24100.0 [1], 33000.0 [2] |
| 1,4-Bis[2-(4-hydroxyphenyl)ethylamino]anthracene-9,10-dione | IC50 | 56700.0 [1], 57000.0 [2] |
| 2-(Phenylamino)benzamide | IC50 | 74000.0 [1], 100000.0 [2] |
| (S)-Benzyl 6-ethanethioamido-1-oxo-1-(phenylamino)hexan-2-ylcarbamate | IC50 | 15000.0 [1], 23000.0 [2] |
| 5-[[2-[(3,5-Dichloro-2-hydroxyphenyl)methylideneamino]phenyl]sulfanylmethyl]-4-(hydroxymethyl)-2-methylpyridin-3-ol | IC50 | 74000.0 [1], 74300.0 [2] |
| (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-Amino-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoyl]amino]-6-(ethanethioylamino)hexanoyl]amino]-4-methylpentanoyl]amino]-4-methylsulfanylbutanoic acid | IC50 | 6300.0 [1], 6400.0 [2], 10000.0 [3] |
| N-[2-(5-Fluoro-1H-indol-3-yl)ethyl]-4-[[(E)-3-[4-[(4-fluorophenyl)methoxy]phenyl]prop-2-enoyl]amino]piperidine-4-carboxamide | IC50 | 51000.0 [1] |
| (2S)-N-[(2S)-5-Acetamido-1-amino-1-oxopentan-2-yl]-6-(carbamothioylamino)-2-[[(2S)-2,5-diacetamidopentanoyl]amino]hexanamide | IC50 | 57200.0 [1], 159100.0 [2] |
| N-Caffeoyltryptophan | IC50 | 8700.0 [1] |
| N-Caffeoyltryptophan | Ki | 5300.0 [1], 9800.0 [2] |
| 3-(4-Bromophenyl)-5-(3-bromopropyl)-1,2,4-oxadiazole | IC50 | 1500.0 [1] |
| 3-(4-Bromophenyl)-5-(3-bromopropyl)-1,2,4-oxadiazole | Ki | 2180.0 [1], 2220.0 [2] |
| Sodium | IC50 | 1200.0 [1] |
| Suramin | IC50 | 1100.0 [1], 1200.0 [2] |
| 5-[4-(4-Chlorobenzoyl)-1-piperazinyl]-8-nitroquinoline | IC50 | 35000.0 [1] |
| 5-{3-[(Furan-2-carbonyl)-amino]-benzoylamino}-2-hydroxy-benzoic acid | IC50 | 751000.0 [1] |
| 5-({3-[4-(Morpholin-4-yl)benzamido]phenyl}methoxy)pyridine-3-carboxamide | IC50 | 16.7 [1] |
| 5-({3-[4-(Morpholin-4-yl)benzamido]phenyl}methoxy)pyridine-3-carboxamide | Ki | 73.0 [1] |
| Para-sirtinol | IC50 | 25900.0 [1], 29900.0 [2] |
| Meta-sirtinol | IC50 | 34500.0 [1], 35700.0 [2] |
| CID 2248572 | IC50 | 2818.38 [1], 9700.0 [2] |
| 2-(2-Chlorobenzoyl)-1H-benzo[f]chromen-3(2H)-one | IC50 | 9400.0 [1] |
| 2,4-Dioxo-N-[4-(pyridin-3-yloxy)phenyl]-1,2,3,4-tetrahydroquinazoline-6-sulfonamide | IC50 | 114000.0 [1] |
| (S)-2-((S)-2-((S)-2-Acetamidopropanamido)-6-ethanethioamidohexanamido)propanoic acid | IC50 | 9800.0 [1] |
| (2S)-8-Bromo-6-chloro-2-pentyl-2,3-dihydrochromen-4-one | IC50 | 1500.0 [1] |
| 5-(5-Benzamidonaphthalen-1-yl)oxypyridine-3-carboxamide | IC50 | 48.3 [1] |
| N-(5-Benzyl-1,3-thiazol-2-yl)-2-[(4,6-dimethylpyrimidin-2-yl)sulfanyl]acetamide | IC50 | 3750.0 [1] |
| N-[5-[(7-Chloronaphthalen-1-yl)methyl]-1,3-thiazol-2-yl]-2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetamide | IC50 | 180.0 [1] |
| (E)-4-((2-Hydroxynaphthalen-1-yl)methyleneamino)-N-(1-phenylethyl)benzenesulfonamide | IC50 | 22600.0 [1] |
| 1-((3-(2-Phenylpropylthio)phenylimino)methyl)naphthalen-2-ol | IC50 | 19200.0 [1] |
| (S)-N-(1-(2-(1H-Indol-3-yl)ethylamino)-1-oxopropan-2-yl)-3-(4-hydroxyphenyl)acrylamide | IC50 | 47000.0 [1] |
| (1R)-8-Methyl-1-(4-methylphenyl)-1,2-dihydrobenzo[f]chromen-3-one | IC50 | 1000.0 [1] |
| 8-Bromo-1-phenyl-1,2-dihydrobenzo[f]chromen-3-one | IC50 | 1000.0 [1], 5200.0 [2] |
| 2-Pentyl-6-chloro-8-bromo-2,3-dihydro-4H-1-benzopyran-4-one | IC50 | 4300.0 [1] |
| 2-Phenethyl-6-chloro-8-bromo-2,3-dihydro-4H-1-benzopyran-4-one | IC50 | 6800.0 [1] |
| N-(2-(1H-Indol-3-yl)ethyl)-4-(3-(4-(benzyloxy)phenyl)acrylamido)piperidine-4-carboxamide | IC50 | 63000.0 [1] |
| N-(1-(2-(1H-Indol-3-yl)ethylamino)-2-methyl-1-oxopropan-2-yl)-3-(4-methoxyphenyl)acrylamide | IC50 | 99000.0 [1] |
| N-(1-(2-(1H-Indol-3-yl)ethylamino)-2-methyl-1-oxopropan-2-yl)-3-(4-hydroxyphenyl)acrylamide | IC50 | 50000.0 [1] |
| N-[2-(5-Fluoro-1H-indol-3-yl)ethyl]-2-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]amino]-2-methylpropanamide | IC50 | 80000.0 [1] |
| (2S)-2-[[(2S)-2-[[(2S)-2,6-Diaminohexanoyl]amino]-6-(ethanethioylamino)hexanoyl]amino]-4-methylpentanoic acid | IC50 | 151000.0 [1] |
| (3Z)-6,7-Dichloro-3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-1H-indol-2-one | IC50 | 28000.0 [1], 28400.0 [2] |
| (2R)-8-Bromo-6-chloro-2-pentyl-2,3-dihydrochromen-4-one | IC50 | 4500.0 [1] |
| SIRT1/2 Inhibitor VII | IC50 | 9000.0 [1], 10000.0 [2] |
| 3-[(5-Chloropyridin-2-yl)-methylsulfamoyl]-N-(4-cyanophenyl)benzamide | IC50 | 6100.0 [1] |
| (2S)-6-Acetamido-2-[[(2S)-6-(carbamothioylamino)-2-[[(2S)-2,6-diacetamidohexanoyl]amino]hexanoyl]amino]hexanamide | IC50 | 5400.0 [1], 30400.0 [2] |
| (2S)-6-Acetamido-2-[[(2S)-2-[[(2S)-2,6-diacetamidohexanoyl]amino]-6-(methylcarbamothioylamino)hexanoyl]amino]hexanamide | IC50 | 1650.0 [1], 2200.0 [2] |
| 5-[[3-(Pyridine-4-carbonylamino)phenyl]methoxy]pyridine-3-carboxamide | IC50 | 34.1 [1] |
| 5-[[3-(Pyridine-4-carbonylamino)phenyl]methoxy]pyridine-3-carboxamide | Ki | 140.0 [1] |
| 5-[[3-(Pyridine-3-carbonylamino)phenyl]methoxy]pyridine-3-carboxamide | IC50 | 193.0 [1] |
| 5-[[3-(Pyridine-3-carbonylamino)phenyl]methoxy]pyridine-3-carboxamide | Ki | 260.0 [1] |
| 5-[[3-[(4-Thiophen-2-ylbenzoyl)amino]phenyl]methoxy]pyridine-3-carboxamide | IC50 | 26.3 [1] |
| 5-[[3-[(4-Thiophen-2-ylbenzoyl)amino]phenyl]methoxy]pyridine-3-carboxamide | Ki | 140.0 [1] |
| (2S)-N-[(2S)-5-Acetamido-1-amino-1-oxopentan-2-yl]-2-[[(2S)-2,5-diacetamidopentanoyl]amino]-6-(ethanethioylamino)hexanamide | IC50 | 2900.0 [1] |
| (2S)-N-[(2S)-6-Acetamido-1-amino-1-oxohexan-2-yl]-2-[[(2S)-2,6-diacetamidohexanoyl]amino]octanediamide | IC50 | 190200.0 [1] |
| (6R,12R)-6,12-Bis(hydroxymethyl)-6,12-diundecyl-1,7-dioxacyclododecane-2,8-dione | IC50 | 176.0 [1], 2000.0 [2] |
| 3-Bromo-4-tert-butyl-N-[[4-[5-(dimethylamino)pentanoylamino]phenyl]carbamothioyl]benzamide | IC50 | 4600.0 [1] |
| N-[[4-[5-(Dimethylamino)pentanoylamino]phenyl]carbamothioyl]-2-methylbenzamide | IC50 | 42500.0 [1], 80700.0 [2] |
| 3-Bromo-N-[[4-[5-(dimethylamino)pentanoylamino]phenyl]carbamothioyl]benzamide | IC50 | 21200.0 [1] |
| 4-Bromo-N-[[4-[5-(dimethylamino)pentanoylamino]phenyl]carbamothioyl]benzamide | IC50 | 39500.0 [1], 55000.0 [2] |
| N-[[4-[5-(Dimethylamino)pentanoylamino]phenyl]carbamothioyl]-4-propan-2-ylbenzamide | IC50 | 5710.0 [1], 32500.0 [2] |
| 3,4-Dichloro-N-[[4-[5-(dimethylamino)pentanoylamino]phenyl]carbamothioyl]benzamide | IC50 | 31900.0 [1] |
| Sunitinib | IC50 | 122700.0 [1] |
| Go-6976 | IC50 | 100000.0 [1] |
| Panobinostat | Ki | 10000.0 [1] |
| Bisindolylmaleimide IV | IC50 | 4700.0 [1] |
| N-Phenylanthranilic acid | IC50 | 100000.0 [1] |
| Hyperforin | IC50 | 28000.0 [1] |
| Kenpaullone | IC50 | 100000.0 [1] |
| Toxoflavin | IC50 | 14400.0 [1] |
| Splitomicin | IC50 | 112900.0 [1] |
| Quisinostat | Ki | 10000.0 [1] |
| Bisindolylmaleimide II | IC50 | 8300.0 [1] |
| 3-[(3,5-Dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1,2-dihydroindol-2-ol | IC50 | 15600.0 [1] |
| Aristoforin | IC50 | 21000.0 [1] |
| (1R,3E,5S,6S,7R)-3-[(3,4-Dihydroxyphenyl)-hydroxymethylidene]-7-[(2E)-3,7-dimethylocta-2,6-dienyl]-6-methyl-1,5-bis(3-methylbut-2-enyl)-6-(4-methylpent-3-enyl)bicyclo[3.3.1]nonane-2,4,9-trione | IC50 | 22000.0 [1] |
| 3H-Naphtho[1,2-d]imidazole-2-thiol | IC50 | 10000.0 [1] |
| 6-Methyl-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide | IC50 | 11500.0 [1] |
| 5-((1H-Indol-3-yl)methylene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione | IC50 | 20300.0 [1] |
| N,N'-Bis(salicylidene)-p-phenylenediamine | IC50 | 58400.0 [1] |
| 5-(4-Benzamido-2-methoxy-5-methylphenylamino)-5-oxo-3-phenylpentanoic acid | IC50 | 1000000.0 [1] |
| 2-Chloro-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-6-carboxamide | IC50 | 2770.0 [1] |
| Bauerine C | IC50 | 87200.0 [1] |